Hazem A Mahdy

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Molecular Dynamics Simulations

Vascular Endothelial Growth Factor

Endoplasmic Reticulum Stress

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hazem Elkady, Osama A El-Dardir, Elwan Alaa, Mohammed S Taghour, Hazem A Mahdy, Mohammed A Dahab, Eslam B Elkaeed, Bshra A Alsfouk, Ibrahim M Ibrahim, Dalal Z Husein, Elsayed E Hafez, Amira Muhammad Galal Darwish, Ahmed M Metwaly, Ibrahim H Eissa
Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors. RSC advances 13 (40) (2023)
Abdulrahman M Saleh, Hazem A Mahdy, Mohamed Ayman El-Zahabi, Ahmed B M Mehany, Mohamed M Khalifa, Ibrahim H Eissa
Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers. RSC advances 13 (32) (2023)
Walid E Elgammal, Hazem Elkady, Hazem A Mahdy, Dalal Z Husein, Aisha A Alsfouk, Bshra A Alsfouk, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly, Ibrahim H Eissa
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies. RSC advances 13 (51) (2023)
Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour, Elwan Alaa, Mohammed A Dahab, Mohamed A Elkady, Elsayed Ge Elsakka, Eslam B Elkaeed, Bshra Ali A Alsfouk, Ibrahim M Ibrahim, Ibrahim H Eissa, Ahmed M Metwaly
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations. Future medicinal chemistry (2023)
Walid E Elgammal, Hazem Elkady, Hazem A Mahdy, Dalal Z Husein, Aisha A Alsfouk, Bshra A Alsfouk, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly, Ibrahim H Eissa
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies. RSC advances 13 (51) (2023)
Ibrahim H Eissa, Radwan El-Haggar, Mohammed A Dahab, Marwa F Ahmed, Hazem A Mahdy, Reem I Alsantali, Alaa Elwan, Nicolas Masurier, Samar S Fatahala
Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Eslam B Elkaeed, Mohammed S Taghour, Hazem A Mahdy, Wagdy M Eldehna, Nehal M El-Deeb, Ahmed M Kenawy, Bshra A Alsfouk, Mohammed A Dahab, Ahmed M Metwaly, Ibrahim H Eissa, Mohamed A El-Zahabi
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Mohammed S Taghour, Hazem A Mahdy, Maher H Gomaa, Ahmed Aglan, Mahmoud Gomaa Eldeib, Alaa Elwan, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Mohamed M Khalifa, Ibrahim H Eissa, Hazem Elkady
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)